<html>
<head>PUBMED IDs for MKNK1</head>
<body bgcolor='#C5F0F2'><h1>MKNK1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18508592/'>The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases).</a> May 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22249268/'>MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.</a> December 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23275061/'>LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.</a> February 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23275061/'>LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models.</a> February 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23365451/'>Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry.</a> May 17  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26323588/'>PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation.</a> August 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27271309/'>Genome-Wide Gene-Sodium Interaction Analyses on Blood Pressure: The Genetic Epidemiology Network of Salt-Sensitivity Study.</a> June 9  2016<br></body></html>
